New Survey—Clinical Trials: Past, Present and Future
SCORR Marketing announced a new survey report that was created in collaboration with Applied Clinical Trials-“Clinical Trials: Past, Present and Future”-is now available for free download.
The survey report describes what clinical trial professionals recognize as the biggest changes over the past decade, and what they expect as they continue evolving into the future.
While survey participants believe the increase in endpoints best explains the growing complexity of clinical trials over the past 10 years, they also predict an increase in the number of adaptive trials will lead to increasing clinical trial complexity in the future.
Clinical Trials: Past, Present and Future is available for download now at scorrmarketing.com.
Applied Clinical Trials published an article detailing perspectives from industry contributors looking at the complexity issues in drug development still to overcome. Read the article here
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Expanding Immune Response Testing to Support Vaccine Development
April 22nd 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and CAR T cell therapy.
